Zhejiang Hisun Pharmaceutical Co., Ltd. provided earnings guidance for first half of 2015. The company predicts a year-on-year decrease of between 60% to 80% in its net profit belonging to shareholders of the listed company in the 1st half of 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.73 CNY | -0.26% | -2.03% | -17.41% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.41% | 1.26B | |
+40.73% | 739B | |
+31.24% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.87% | 240B | |
+9.21% | 210B | |
-5.15% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd. Provides Earnings Guidance for First Half of 2015